Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 2
1955 2
1956 3
1957 7
1958 1
1959 1
1960 4
1961 6
1962 2
1963 4
1964 22
1965 23
1966 18
1967 13
1968 20
1969 11
1970 18
1971 21
1972 28
1973 29
1974 23
1975 33
1976 18
1977 29
1978 25
1979 22
1980 21
1981 20
1982 18
1983 22
1984 17
1985 19
1986 22
1987 27
1988 16
1989 19
1990 6
1991 12
1992 17
1993 18
1994 17
1995 16
1996 10
1997 11
1998 21
1999 18
2000 24
2001 22
2002 24
2003 15
2004 24
2005 27
2006 19
2007 28
2008 31
2009 28
2010 23
2011 33
2012 20
2013 30
2014 34
2015 32
2016 41
2017 28
2018 26
2019 36
2020 34
2021 34
2022 45
2023 62
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

1,388 results

Results by year

Filters applied: . Clear all
Page 1
Factor XI inhibitors: cardiovascular perspectives.
De Caterina R, Prisco D, Eikelboom JW. De Caterina R, et al. Eur Heart J. 2023 Jan 21;44(4):280-292. doi: 10.1093/eurheartj/ehac464. Eur Heart J. 2023. PMID: 36263776 Review.
Factor XI Deficiency.
Lewandowska MD, Connors JM. Lewandowska MD, et al. Hematol Oncol Clin North Am. 2021 Dec;35(6):1157-1169. doi: 10.1016/j.hoc.2021.07.012. Epub 2021 Sep 15. Hematol Oncol Clin North Am. 2021. PMID: 34535287 Free article. Review.
News at XI: moving beyond factor Xa inhibitors.
Fredenburgh JC, Weitz JI. Fredenburgh JC, et al. J Thromb Haemost. 2023 Jul;21(7):1692-1702. doi: 10.1016/j.jtha.2023.04.021. Epub 2023 Apr 26. J Thromb Haemost. 2023. PMID: 37116752 Review.
Pharmacology and Clinical Development of Factor XI Inhibitors.
Greco A, Laudani C, Spagnolo M, Agnello F, Faro DC, Finocchiaro S, Legnazzi M, Mauro MS, Mazzone PM, Occhipinti G, Rochira C, Scalia L, Capodanno D. Greco A, et al. Circulation. 2023 Mar 14;147(11):897-913. doi: 10.1161/CIRCULATIONAHA.122.062353. Epub 2023 Mar 13. Circulation. 2023. PMID: 36913497 Review.
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis.
Galli M, Laborante R, Ortega-Paz L, Franchi F, Rollini F, D'Amario D, Capodanno D, Tremoli E, Gibson CM, Mehran R, Angiolillo DJ. Galli M, et al. Thromb Haemost. 2023 Jun;123(6):576-584. doi: 10.1055/a-2043-0346. Epub 2023 Feb 25. Thromb Haemost. 2023. PMID: 36841245
Factor XI/XIa Inhibitors … Here We Go Again!
Spears J, Strony J, Kowey PR. Spears J, et al. Am J Med. 2023 Jun;136(6):512-513. doi: 10.1016/j.amjmed.2023.01.016. Epub 2023 Feb 2. Am J Med. 2023. PMID: 36739063 No abstract available.
Abelacimab for Prevention of Venous Thromboembolism.
Verhamme P, Yi BA, Segers A, Salter J, Bloomfield D, Büller HR, Raskob GE, Weitz JI; ANT-005 TKA Investigators. Verhamme P, et al. N Engl J Med. 2021 Aug 12;385(7):609-617. doi: 10.1056/NEJMoa2105872. Epub 2021 Jul 19. N Engl J Med. 2021. PMID: 34297496 Clinical Trial.
1,388 results